Might patients benefit from oral iron therapy following operative treatment of breast carcinoma?

Eur J Surg Oncol. 2001 Nov;27(7):621-5. doi: 10.1053/ejso.2001.1205.

Abstract

Aims: To assess the changes in blood haemoglobin concentration and serum iron indices as a consequence of breast operations for cancer in our unit.

Methods: Haematological parameters were measured in 109 patients undergoing definitive operative treatment for breast carcinoma.

Results: A mean fall in haemoglobin of 2.1 g (P=0.001) occurred in patients undergoing mastectomy and axillary clearance and of 1.3 g (P<0.001) in patients undergoing wide local excision and axillary clearance. The transferrin saturation (serum iron/total iron binding capacity) in both sets of patients after surgery fell on average to levels that would be expected to impair subsequent red cell production.

Conclusion: The changes in iron indices that occurred were unrelated to the degree of blood loss consistent with a possible inflammatory effect of the operation. Oral iron therapy is unlikely to be of benefit to operative breast patients if they have normal pre-operative iron stores.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Iron-Deficiency / drug therapy
  • Anemia, Iron-Deficiency / etiology
  • Blood Loss, Surgical / physiopathology
  • Breast Neoplasms / surgery*
  • Carcinoma / surgery*
  • Female
  • Hemoglobins / metabolism
  • Humans
  • Iron / blood
  • Iron / therapeutic use*
  • Iron Deficiencies*
  • Mastectomy*
  • Middle Aged
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / etiology
  • Transferrin / metabolism

Substances

  • Hemoglobins
  • Transferrin
  • Iron